申请人:Shanghai Shaletech Technology Co., Ltd.
公开号:EP3181557A1
公开(公告)日:2017-06-21
The present invention relates to the technical field of medicine, and specifically relates to the carboxylic acid compound represented by the chemical formula I or chemical formula II, and a pharmaceutically acceptable salt, a prodrug, and a solvate thereof, and a method for preparation thereof, as well as a pharmaceutical composition containing the described substances, and a use thereof.
本发明涉及医药技术领域,具体涉及化学式 I 或化学式 II 所代表的羧酸化合物及其药学上可接受的盐、原药和溶液及其制备方法,以及含有所述物质的药物组合物及其用途。